SG11201901199WA - Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells - Google Patents

Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells

Info

Publication number
SG11201901199WA
SG11201901199WA SG11201901199WA SG11201901199WA SG11201901199WA SG 11201901199W A SG11201901199W A SG 11201901199WA SG 11201901199W A SG11201901199W A SG 11201901199WA SG 11201901199W A SG11201901199W A SG 11201901199WA SG 11201901199W A SG11201901199W A SG 11201901199WA
Authority
SG
Singapore
Prior art keywords
singapore
cd45ra
expansion
international
ridge road
Prior art date
Application number
SG11201901199WA
Other languages
English (en)
Inventor
Sudipto Bari
Christina Li Lin Chai
Gigi Ngar Chee Chiu
William Ying Khee Hwang
Joo Leng Low
Qixing Zhong
Original Assignee
Nat Univ Singapore
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Singapore, Singapore Health Serv Pte Ltd filed Critical Nat Univ Singapore
Publication of SG11201901199WA publication Critical patent/SG11201901199WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201901199WA 2016-08-18 2017-08-18 Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells SG11201901199WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201606886V 2016-08-18
PCT/SG2017/050409 WO2018048346A1 (en) 2016-08-18 2017-08-18 Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells

Publications (1)

Publication Number Publication Date
SG11201901199WA true SG11201901199WA (en) 2019-03-28

Family

ID=61562838

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202101478YA SG10202101478YA (en) 2016-08-18 2017-08-18 Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells
SG11201901199WA SG11201901199WA (en) 2016-08-18 2017-08-18 Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202101478YA SG10202101478YA (en) 2016-08-18 2017-08-18 Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells

Country Status (10)

Country Link
US (1) US20190359941A1 (de)
EP (1) EP3500562B1 (de)
JP (1) JP7168552B2 (de)
KR (1) KR102522572B1 (de)
CN (1) CN109890805B (de)
AU (1) AU2017325511B2 (de)
ES (1) ES2968146T3 (de)
MY (1) MY197282A (de)
SG (2) SG10202101478YA (de)
WO (1) WO2018048346A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110511909B (zh) * 2019-07-29 2022-01-04 吉林大学 体外扩增造血干细胞的生长因子组合物及其应用
CN110904038B (zh) * 2019-12-13 2023-09-12 深圳市蓝思人工智能医学研究院 一种间充质干细胞及其应用
KR20230033740A (ko) * 2020-07-10 2023-03-08 베크만 컬터, 인코포레이티드 세포 분석을 위한 자동화된 샘플 제조 플랫폼

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100362A1 (es) * 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
WO2012141971A2 (en) 2011-04-05 2012-10-18 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for rejuvenation and expansion of stem cells
WO2013059357A1 (en) * 2011-10-19 2013-04-25 Stowers Institute For Medical Research Methods, kits, and compositions for stem cell self-renewal
US9428732B2 (en) * 2011-12-05 2016-08-30 Primorigen Biosciences, Inc. Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
AU2012347534B2 (en) * 2011-12-08 2018-01-25 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
DK2807165T3 (da) * 2012-01-27 2019-07-15 Univ Montreal Pyrimido[4,5-b]indol-derivater og anvendelse deraf i ekspansionen af hæmatopoietiske stamceller
MX2014015419A (es) * 2012-06-14 2015-07-14 Janssen Biotech Inc Tratamiento de celulas pluripotentes.
EP3102207B1 (de) * 2014-02-07 2022-05-11 Agency For Science, Technology And Research 2,4,5-trisubstituierte azolbasierte casein-kinase-1-hemmer zur induzierung von kardiomyogenese
JP2017511132A (ja) * 2014-03-26 2017-04-20 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． ヒト造血幹／前駆細胞のエクスビボ拡大のための組成物および方法
CA2946446C (en) * 2014-04-22 2020-11-03 Universite De Montreal Pyrido-pyrrolo-pyrimidine and pyrido-indole compounds, pharmaceutical compositions containing same and their use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells
CN105713879B (zh) * 2014-12-01 2020-05-08 顺昊细胞生物技术（天津）股份有限公司 一种用于脐带血造血干细胞扩增的培养体系及其应用
ES2908041T3 (es) 2015-10-27 2022-04-27 Childrens Hospital Med Ct Uso de inhibidores de MAPK para reducir la pérdida de células madre hematopoyéticas durante el cultivo ex vivo y la manipulación genética

Also Published As

Publication number Publication date
US20190359941A1 (en) 2019-11-28
EP3500562A1 (de) 2019-06-26
KR20190039988A (ko) 2019-04-16
EP3500562B1 (de) 2023-11-15
JP2019528066A (ja) 2019-10-10
AU2017325511A1 (en) 2019-03-07
ES2968146T3 (es) 2024-05-08
KR102522572B1 (ko) 2023-04-17
EP3500562A4 (de) 2020-03-18
SG10202101478YA (en) 2021-03-30
JP7168552B2 (ja) 2022-11-09
MY197282A (en) 2023-06-09
AU2017325511B2 (en) 2021-12-09
CN109890805B (zh) 2023-04-04
WO2018048346A1 (en) 2018-03-15
CN109890805A (zh) 2019-06-14

Similar Documents

Publication Publication Date Title
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201907566TA (en) Methods and compositions for labeling cells
SG11201901210UA (en) Ferroelectric memory cells
SG11201906623SA (en) A fluid-driven actuator and its applications
SG11201900400QA (en) Bispecific antibody-like binding proteins specifically binding to cd3 and cd123
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201805268XA (en) T cell receptors specific for the ny-eso-1 tumor antigen-hla-a*02 complex
SG11201808762XA (en) Diagnostic methods for patient specific therapeutic decision making in cancer care
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201901628XA (en) Methods and compositions for spinal cord cells
SG11201904535VA (en) Prevention and treatment of bone and cartilage damage or disease
SG11201901494UA (en) Acid-alpha glucosidase variants and uses thereof
SG11201908472VA (en) Compositions and methods for activating nk cells
SG11201901199WA (en) Substituted azole derivatives for generation, proliferation and differentiation of hematopoietic stem and progenitor cells
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201807281TA (en) Polyethylene composition, method of making the same, and films made therefrom
SG11201809341PA (en) Mobile robot
SG11201804643PA (en) Indicator device
SG11201806512VA (en) Copanlisib biomarkers
SG11201808106YA (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201903329WA (en) Method for preparing electrocompetent yeast cells, and method for using said cells
SG11201809749VA (en) Computer systems and methods for implementing in-memory data structures
SG11201408171SA (en) Fbxo3 inhibitors
SG11201900043TA (en) Antibody formulations